Home/Pipeline/DE-120 (Ciclosporin ophthalmic gel)

DE-120 (Ciclosporin ophthalmic gel)

Dry Eye Disease

Phase 3Active

Key Facts

Indication
Dry Eye Disease
Phase
Phase 3
Status
Active
Company

About Rohto Pharmaceutical

Rohto Pharmaceutical is a major Japanese healthcare company with a century-long history, specializing in OTC eye care, prescription pharmaceuticals, and consumer health products. Its strategic focus includes expanding its global footprint, particularly in Asia and the Americas, and advancing a pipeline of novel therapeutics in ophthalmology and dermatology. The company's strength lies in its powerful consumer brands, robust R&D capabilities in formulation technology, and a diversified business model that balances stable OTC revenue with growth from innovative prescription drugs.

View full company profile